Raymond James & Associates’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,757
| Closed | -$213K | – | 3861 |
|
|
2023
Q2 | $213K | Buy |
+6,757
| New | +$213K | ﹤0.01% | 3417 |
|
|
2023
Q1 | – | Sell |
-7,554
| Closed | -$229K | – | 3905 |
|
|
2022
Q4 | $229K | Sell |
7,554
-1,847
| -20% | -$56.1K | ﹤0.01% | 3348 |
|
|
2022
Q3 | $283K | Sell |
9,401
-5,410
| -37% | -$163K | ﹤0.01% | 3204 |
|
|
2022
Q2 | $410K | Buy |
14,811
+600
| +4% | +$16.6K | ﹤0.01% | 3019 |
|
|
2022
Q1 | $478K | Buy |
14,211
+34
| +0.2% | +$1.14K | ﹤0.01% | 3089 |
|
|
2021
Q4 | $599K | Sell |
14,177
-814
| -5% | -$34.4K | ﹤0.01% | 2946 |
|
|
2021
Q3 | $682K | Sell |
14,991
-10,077
| -40% | -$458K | ﹤0.01% | 2836 |
|
|
2021
Q2 | $1.23M | Buy |
25,068
+1,583
| +7% | +$77.4K | ﹤0.01% | 2451 |
|
|
2021
Q1 | $1.18M | Buy |
23,485
+2,956
| +14% | +$149K | ﹤0.01% | 2392 |
|
|
2020
Q4 | $1.05M | Buy |
20,529
+2,839
| +16% | +$145K | ﹤0.01% | 2306 |
|
|
2020
Q3 | $728K | Sell |
17,690
-976
| -5% | -$40.2K | ﹤0.01% | 2365 |
|
|
2020
Q2 | $781K | Buy |
18,666
+1,265
| +7% | +$52.9K | ﹤0.01% | 2315 |
|
|
2020
Q1 | $552K | Sell |
17,401
-978
| -5% | -$31K | ﹤0.01% | 2351 |
|
|
2019
Q4 | $777K | Sell |
18,379
-15,774
| -46% | -$667K | ﹤0.01% | 2425 |
|
|
2019
Q3 | $1.08M | Sell |
34,153
-1,359
| -4% | -$42.9K | ﹤0.01% | 2164 |
|
|
2019
Q2 | $1.28M | Sell |
35,512
-2,991
| -8% | -$108K | ﹤0.01% | 2071 |
|
|
2019
Q1 | $1.39M | Sell |
38,503
-21,464
| -36% | -$777K | ﹤0.01% | 2003 |
|
|
2018
Q4 | $1.69M | Sell |
59,967
-108,279
| -64% | -$3.05M | ﹤0.01% | 1764 |
|
|
2018
Q3 | $6.62M | Buy |
168,246
+50,942
| +43% | +$2.01M | 0.01% | 1052 |
|
|
2018
Q2 | $4.37M | Buy |
117,304
+39,858
| +51% | +$1.49M | 0.01% | 1278 |
|
|
2018
Q1 | $2.65M | Buy |
77,446
+6,840
| +10% | +$234K | ﹤0.01% | 1523 |
|
|
2017
Q4 | $2.32M | Buy |
70,606
+23,157
| +49% | +$759K | ﹤0.01% | 1597 |
|
|
2017
Q3 | $1.48M | Buy |
47,449
+11,322
| +31% | +$353K | ﹤0.01% | 1852 |
|
|
2017
Q2 | $1.01M | Sell |
36,127
-88,045
| -71% | -$2.45M | ﹤0.01% | 2022 |
|
|
2017
Q1 | $3.2M | Sell |
124,172
-21,650
| -15% | -$558K | 0.01% | 1249 |
|
|
2016
Q4 | $3.34M | Sell |
145,822
-2,745
| -2% | -$62.9K | 0.01% | 1196 |
|
|
2016
Q3 | $3.88M | Buy |
148,567
+131,890
| +791% | +$3.44M | 0.01% | 1077 |
|
|
2016
Q2 | $378K | Buy |
16,677
+490
| +3% | +$11.1K | ﹤0.01% | 2257 |
|
|
2016
Q1 | $355K | Sell |
16,187
-1,467
| -8% | -$32.2K | ﹤0.01% | 2226 |
|
|
2015
Q4 | $561K | Buy |
17,654
+7,215
| +69% | +$229K | ﹤0.01% | 1929 |
|
|
2015
Q3 | $291K | Buy |
+10,439
| New | +$291K | ﹤0.01% | 2142 |
|